Search results for "Chronic"

showing 10 items of 3309 documents

Two Patients With History of STEC-HUS, Posttransplant Recurrence and Complement Gene Mutations

2013

Hemolytic uremic syndrome (HUS) is a disease of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. About 90% of cases are secondary to infections by Escherichia coli strains producing Shiga-like toxins (STEC-HUS), while 10% are associated with mutations in genes encoding proteins of complement system (aHUS). We describe two patients with a clinical history of STEC-HUS, who developed end-stage renal disease (ESRD) soon after disease onset. They received a kidney transplant but lost the graft for HUS recurrence, a complication more commonly observed in aHUS. Before planning a second renal transplantation, the two patients underwent genetic screening for aHUS-associat…

Shiga-toxinGraft RejectionMaleDNA Primer030232 urology & nephrologyEscherichia coli InfectionGene mutationurologic and male genital diseasesGastroenterology0302 clinical medicineRecurrenceRisk Factorshemic and lymphatic diseasesImmunology and AllergyPharmacology (medical)gene mutationKidney transplantationEscherichia coli Infections0303 health sciencesKidneymedicine.diagnostic_testShiga-Toxigenic Escherichia coliAntigens CD46Microangiopathic hemolytic anemiaMiddle AgedPrognosisfemale genital diseases and pregnancy complications3. Good healthPedigreemedicine.anatomical_structureComplement Factor IComplement factor I; gene mutation; hemolytic uremic syndrome; kidney transplantation; membrane cofactor protein; Shiga-toxin; Adult; Antigens CD46; Case-Control Studies; Complement Factor I; DNA Primers; Escherichia coli Infections; Female; Genetic Testing; Graft Rejection; Hemolytic-Uremic Syndrome; Heterozygote; Humans; Kidney Failure Chronic; Kidney Transplantation; Male; Middle Aged; Mutation; Pedigree; Prognosis; Recurrence; Risk Factors; Shiga-Toxigenic Escherichia coli; Thrombocytopenia; Young Adult; Transplantation; Immunology and Allergy; Pharmacology (medical)FemaleCase-Control StudieHumanAdultmedicine.medical_specialtyHeterozygotePrognosiComplement factor IMembrane Cofactor Protein03 medical and health sciencesYoung AdultInternal medicinemedicineHumansGenetic Testing030304 developmental biologyGenetic testingDNA PrimersTransplantationbusiness.industryCD46Risk Factormedicine.diseaseKidney TransplantationThrombocytopeniaTransplantationCase-Control StudiesImmunologyHemolytic-Uremic SyndromeMutationhemolytic uremic syndromeKidney Failure ChronicbusinessAmerican Journal of Transplantation
researchProduct

Sibship and Self-Esteem in Children With Asthma

2016

This study has explored the valence of sibship that may empower the self-esteem of children with asthma at the interpersonal, environmental control competence, emotionality management, and body-image levels. It has been assumed that the relationship between siblings may have a moderating effect on the negative impact that asthma has on child’s development. Seventy children suffering from chronic asthma have been involved: 40 children with siblings (experimental group) and 30 sibling-free children (control group). The children with asthma have exhibited higher levels of self-esteem in comparison with the sibling-free children. The results of the study, at the clinical significance level, hig…

Sibshipmedicine.medical_specialtymedia_common.quotation_subjectlcsh:MedicineInterpersonal communicationDevelopmentPediatricsArticle03 medical and health sciencesSettore M-PSI/04 - Psicologia Dello Sviluppo E Psicologia Dell'Educazione0302 clinical medicineChronic asthmaEmotionalitySelf-esteemmedicineClinical significance030212 general & internal medicineValence (psychology)PsychiatryChildrenAsthmamedia_commonbusiness.industrySelf-esteem; Sibship; Asthma; Children; Developmentlcsh:Rlcsh:RJ1-570Self-esteemlcsh:Pediatricsmedicine.diseaseAsthmarespiratory tract diseases030228 respiratory systembusinessself-esteem; sibship; asthma; children; developmentClinical psychologyPediatric Reports; Volume 8; Issue 2; Pages: 6370
researchProduct

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1)…

2014

Although the addition of the HCV NS3/4A protease inhibitors boceprevir and telaprevir to pegylated interferon (peginterferon) alfa plus ribavirin has improved sustained virological response (SVR) in treatment-naive and treatment-experienced patients infected with hepatitis C virus (HCV) genotype 1, the regimens have a high pill burden and are associated with increased rates and severity of adverse events, such as anaemia and rash. The efficacy and safety of the combination of simeprevir, a one pill, once-daily, oral HCV NS3/4A protease inhibitor, plus peginterferon alfa 2a plus ribavirin were assessed in treatment-naive patients with HCV genotype 1 infection.In QUEST-1, a phase 3, randomise…

SimeprevirAdultMalemedicine.medical_specialtyGenotypeHepatitis C virusHepacivirusmedicine.disease_causeGastroenterologyAntiviral AgentsDrug Administration ScheduleTelaprevirPolyethylene Glycolschemistry.chemical_compoundDouble-Blind MethodPegylated interferonSimeprevirBoceprevirInternal medicineRibavirinmedicineHumanschronic hepatitis CSulfonamidesbusiness.industryRibavirinvirus diseasesInterferon-alphaGeneral MedicineHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseVirologydigestive system diseasesRecombinant ProteinsTreatment OutcomechemistryDrug Therapy CombinationFemalebusinessHeterocyclic Compounds 3-Ringmedicine.drugPeginterferon alfa-2a
researchProduct

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

2016

Background & Aims: All oral direct acting antivirals (DAA) have been shown to improve the liver function of patients with decompensated cirrhosis but it is presently unknown whether this clinical improvement may lead to the delisting of some patients. The aim of this study was to assess if and which patients can be first inactivated due to clinically improvement and subsequently delisted in a real life setting. Methods: 103 consecutive listed patients without hepatocellular carcinoma were treated with different DAA combinations in 11 European centres between February 2014 and February 2015. Results: The cumulative incidence of inactivated and delisted patients by competing risk analysis…

Simeprevirmedicine.medical_specialtyCarcinoma HepatocellularCirrhosisWaiting ListsSofosbuvirmedicine.medical_treatmentDelistingLiver transplantationGastroenterologyDirect acting antivirals03 medical and health sciencesLiver disease0302 clinical medicineModel for End-Stage Liver DiseaseSDG 3 - Good Health and Well-beingInternal medicinemedicineHumansCumulative incidenceCirrhosiLiver transplantationHepatologybusiness.industryLiver Neoplasms[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyHepatitis C Chronicmedicine.disease3. Good healthCirrhosis030220 oncology & carcinogenesisHCV030211 gastroenterology & hepatologyDirect acting antiviralLiver functionbusinessmedicine.drug
researchProduct

PTH-137 Safety and efficacy of simeprevir (SMV) plus PEG-IFN/RBV in treatment-naÏve chronic hepatitis c genotype 1 patients eligible for 12 weeks of …

2015

Introduction HPC3014 is a Phase 3, open-label study to assess if response to SMV+Peg-IFN/RBV at Week 2 can allow shortening of treatment to 12 weeks, irrespective of baseline and on-treatment factors. Method Treatment-naive chronic HCV G1-infected patients with no-to-moderate fibrosis (METAVIR F0–F2) were recruited. In patients with HCV-RNA ® Taqman ® lower limit of quantification: 25 IU/mL, lower limit of detection: 15 IU/mL]) at Week 2 and undetectable at Weeks 4 and 8, all treatments were stopped at Week 12 (12-week group). If these criteria were not met, Peg-IFN/RBV was continued to Week 24 (in one case extended to Week 48). Results 123/163 (76%) patients treated were eligible for the 1…

Simeprevirmedicine.medical_specialtybusiness.industryGastroenterologyNeutropeniamedicine.diseaseRashTherapy naiveChronic hepatitisInternal medicineGenotypemedicineIn patientmedicine.symptombusinessViral loadGut
researchProduct

Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS)

2020

Aims: The role of non‐invasive telemedicine (TM) combining telemonitoring and teleintervention by videoconference (VC) in patients recently admitted due to heart failure (HF) (‘vulnerable phase’ HF patients) is not well established. The aim of the Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS) trial is to assess the impact on clinical outcomes of implementing a TM service based on mobile health (mHealth), which includes remote daily monitoring of biometric data and symptom reporting (telemonitoring) combined with VC structured, nurse‐based follow‐up (teleintervention). The results will be compared with those of the comprehensive HF usual care (UC) strateg…

Sintomatología61medicine.medical_specialtyTelemedicineStudy DesignsHospitals -- PacientsAsistencia sanitariaHeart failureInsuficiència cardíaca616.1030204 cardiovascular system & hematologySímptomes03 medical and health sciences0302 clinical medicineAssistència sanitàriaHospitals -- PatientsHealth caremedicineeHealthDiseases of the circulatory (Cardiovascular) systemTransitional careDecompensationTransitional careVideoconferències030212 general & internal medicinemHealthTelecommunication in medicineHospitalizadosStudy Designbusiness.industryVideo conferencingInsuficiencia cardíacaHealth careChronic care modelTelemedicinamedicine.diseaseChronic heart failureTelemedicinemHealthOutcomes researchRC666-701Heart failureVideoconferenciaSymptomsEmergency medicineOutcomes researchCardiology and Cardiovascular MedicinebusinessTelecomunicació en medicinaESC Heart Failure
researchProduct

Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study

2003

Objectives: Our objectives were to test the hypothesis that, in the geriatric population, chronic airway obstruction is associated with a higher prevalence of sleep disturbances; to identify the main correlates of sleep disturbances, and to verify whether asthma and COPD patients have different patterns of sleep disturbances. Methods: The EPESE questionnaire was administered to 734 patients aged 65 years and over with asthma or chronic obstructive pulmonary disease (cases) and 1237 individuals of comparable age who were free of respiratory disease but not of other chronic conditions (controls). Four sleep disturbances were quantified: difficulty in falling asleep, nocturnal awakening, morni…

Sleep Wake DisordersMalemedicine.medical_specialtyNeuropsychological TestsSettore MED/10 - Malattie Dell'Apparato RespiratorioLogistic regressionSeverity of Illness IndexCognition DisorderPulmonary Disease Chronic ObstructivePhysiology (medical)Internal medicineSurveys and QuestionnairesmedicineHumansSurveys and QuestionnaireSleep Wake DisorderWakefulnessDepression (differential diagnoses)Bronchodilator AgentAsthmaMorningAgedSleep disorderDepressive Disorder Majorbusiness.industryRespiratory diseasemedicine.diseaseSleep in non-human animalsBronchodilator AgentsSpirometryPhysical therapyGeriatric Depression ScaleFemaleNeuropsychological TestNeurology (clinical)businessCognition DisordersHuman
researchProduct

A cognitive-behavioural intervention improves cognition in caregivers of people with autism spectrum disorder: A pilot study

2017

Abstract As postulated by the stress process model, chronically stressed individuals, such as caregivers of people with chronic psychological disorders, have poorer cognitive performance and higher age-related cognitive decline than individuals not exposed to chronic stress. When analysing this topic in caregivers, the majority of research has been conducted in populations in which the care recipient has dementia and/or Alzheimer's disease, while relatively few studies have analysed cognition in caregivers of offspring with autism spectrum disorder (ASD). The main objective of this pilot study was to analyse the effect of a cognitive-behavioural intervention on cognition in caregivers of pe…

Social PsychologyCognitive-behavioural interventionDevelopmental psychology03 medical and health sciencesCognition0302 clinical medicineRespite careDevelopmental and Educational PsychologymedicineVerbal fluency testDementia030212 general & internal medicineNeuropsychological assessmentAutism spectrum disorderCognitive declineApplied Psychologymedicine.diagnostic_testCognitive flexibilityCognitionmedicine.diseaseCaregiversAutism spectrum disorderChronic stressPsychology030217 neurology & neurosurgeryClinical psychologyPsychosocial Intervention
researchProduct

Methods for Evaluating the Interaction Between Social Stress and Environmental Enrichment in Animal Models of Nicotine Addiction

2019

The environmental enrichment (EE) paradigm has been evaluated as a means of counteracting some of the consequences of chronic stress in rodents as well as a model of protective environment against drug abuse development. In the present chapter, our main aim is to describe the models of EE and chronic social stress and how they can be applied jointly in order to evaluate the effects of early psychosocial stress in animals exposed of different environments (enriched environment or standard environment). Furthermore, both paradigms could be applied in animal models of nicotine addiction, so the guidelines for the application of a chronic oral nicotine treatment in mice will be described. The h…

Social stressEnvironmental enrichmentAddictionmedia_common.quotation_subjectmedicine.diseaseNicotine Addiction030227 psychiatryNicotineSubstance abuse03 medical and health sciences0302 clinical medicinePsychosocial stressmedicineChronic stressPsychology030217 neurology & neurosurgeryClinical psychologymedia_commonmedicine.drug
researchProduct

N6 -Methyladenosine Modification in Chronic Stress Response Due to Social Hierarchy Positioning of Mice

2021

Appropriately responding to stressful events is essential for maintaining health and well-being of any organism. Concerning social stress, the response is not always as straightforward as reacting to physical stressors, e.g., extreme heat, and thus has to be balanced subtly. Particularly, regulatory mechanisms contributing to gaining resilience in the face of mild social stress are not fully deciphered yet. We employed an intrinsic social hierarchy stress paradigm in mice of both sexes to identify critical factors for potential coping strategies. While global transcriptomic changes could not be observed in male mice, several genes previously reported to be involved in synaptic plasticity, l…

Social stressMethyltransferase complexbehaviorQH301-705.5sex differenceStressorCell BiologyBiologydominancechemistry.chemical_compoundtranscriptomicschemistryCorticosteroneepigenetic modificationSynaptic plasticityChronic stressmethyltransferaseMRNA methylationN6-MethyladenosineBiology (General)NeuroscienceDevelopmental BiologyFrontiers in Cell and Developmental Biology
researchProduct